When it comes to commitment to patients, BioMarin has a lock on it. Each Rare Disease Day, we recognize people impacted by a rare genetic disease, as well as advocates…
Read More »achondroplasia
Achondroplasia, the most common cause of short stature, or dwarfism, affects nearly all of the bones in the body. As a result, on average people with achondroplasia are around 25%…
Read More »
In the first installment of our new ‘Patients Are Counting On Us’ series, KK and her family talk about how they approach living with achondroplasia. To say that KK does…
Read More »
BioMarin Pharmaceutical Inc. stands as a beacon of innovation in biotechnology, pioneering treatments for rare genetic disorders. BioMarin Pharmaceutical: Revolutionizing Treatment for Rare Genetic Diseases Based in San Rafael, California,…
Read More »
Hear from patients whose lives were changed by genetic medicine experts at Johns Hopkins. Learn about their journey and what you can expect from specialists in the Department of Genetic…
Read More »